Literature DB >> 20105118

Recent progress in the development of synthetic hybrids of natural or unnatural bioactive compounds for medicinal chemistry.

Svetlana B Tsogoeva1.   

Abstract

The present mini-review highlights the recent developments on different classes of synthetic hybrids of natural and/or unnatural bioactive compounds, the utilization of which is very promising, as distinct features of each component can be hybridized and their properties leveraged. Particular stress is put on the respective mode of action and the corresponding rationale behind covalent combinations of various bioactive agents to increase their therapeutic potential, facilitate their administration, to reduce harmful side effects and/or to overcome the problem of multi-drug resistance. This rather recent approach has already found applications in the development of new anti-cancer, anti-Alzheimer, anti-malaria, anti-microbial therapeutics and other novel compounds with unprecedented bioactivity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20105118     DOI: 10.2174/138955710791608280

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  26 in total

1.  Design, synthesis and biological evaluation of arylcinnamide hybrid derivatives as novel anticancer agents.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Mariem Chayah; M Encarnacion Camacho; Filippo Prencipe; Ernest Hamel; Francesca Consolaro; Giuseppe Basso; Giampietro Viola
Journal:  Eur J Med Chem       Date:  2014-05-10       Impact factor: 6.514

2.  Novel hybrid-type antimicrobial agents targeting the switch region of bacterial RNA polymerase.

Authors:  Fumika Yakushiji; Yuko Miyamoto; Yuki Kunoh; Reiko Okamoto; Hidemasa Nakaminami; Yuri Yamazaki; Norihisa Noguchi; Yoshio Hayashi
Journal:  ACS Med Chem Lett       Date:  2013-01-11       Impact factor: 4.345

3.  Antibacterial evaluation and molecular docking studies of pyrazole-thiosemicarbazones and their pyrazole-thiazolidinone conjugates.

Authors:  Oluwakemi Ebenezer; Ashona Singh-Pillay; Neil A Koorbanally; Parvesh Singh
Journal:  Mol Divers       Date:  2020-02-21       Impact factor: 2.943

4.  Synthesis of Thymoquinone-Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents.

Authors:  Tony Fröhlich; Christoph Reiter; Mohamed E M Saeed; Corina Hutterer; Friedrich Hahn; Maria Leidenberger; Oliver Friedrich; Barbara Kappes; Manfred Marschall; Thomas Efferth; Svetlana B Tsogoeva
Journal:  ACS Med Chem Lett       Date:  2017-12-21       Impact factor: 4.345

5.  Construction of NH-Unprotected Spiropyrrolidines and Spiroisoindolines by [4+1] Cyclizations of γ-Azidoboronic Acids with Cyclic N-Sulfonylhydrazones.

Authors:  Lucía López; María-Paz Cabal; Carlos Valdés
Journal:  Angew Chem Int Ed Engl       Date:  2021-11-25       Impact factor: 16.823

6.  Facile access to potent antiviral quinazoline heterocycles with fluorescence properties via merging metal-free domino reactions.

Authors:  Felix E Held; Anton A Guryev; Tony Fröhlich; Frank Hampel; Axel Kahnt; Corina Hutterer; Mirjam Steingruber; Hanife Bahsi; Clemens von Bojničić-Kninski; Daniela S Mattes; Tobias C Foertsch; Alexander Nesterov-Mueller; Manfred Marschall; Svetlana B Tsogoeva
Journal:  Nat Commun       Date:  2017-05-02       Impact factor: 14.919

7.  Deeper Insight into the Six-Step Domino Reaction of Aldehydes with Malononitrile and Evaluation of Antiviral and Antimalarial Activities of the Obtained Bicyclic Products.

Authors:  Christina M Bock; Gangajji Parameshwarappa; Simon Bönisch; Walter Bauer; Corina Hutterer; Maria Leidenberger; Oliver Friedrich; Manfred Marschall; Barbara Kappes; Andreas Görling; Svetlana B Tsogoeva
Journal:  ChemistryOpen       Date:  2017-04-26       Impact factor: 2.911

8.  Gold-catalyzed oxycyclization of allenic carbamates: expeditious synthesis of 1,3-oxazin-2-ones.

Authors:  Benito Alcaide; Pedro Almendros; M Teresa Quirós; Israel Fernández
Journal:  Beilstein J Org Chem       Date:  2013-04-26       Impact factor: 2.883

9.  Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas.

Authors:  Annemarie Ackermann; Aysun Çapcı Karagöz; Ali Ghoochani; Michael Buchfelder; Ilker Eyüpoglu; Svetlana B Tsogoeva; Nicolai Savaskan
Journal:  Oncotarget       Date:  2017-06-07

Review 10.  Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis.

Authors:  Anna Pawełczyk; Katarzyna Sowa-Kasprzak; Dorota Olender; Lucjusz Zaprutko
Journal:  Int J Mol Sci       Date:  2018-04-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.